Matches in Nanopublications for { ?s ?p "[This study enables us to estimate the frequency of the SPG3A mutations in France at 39% in families with young-onset autosomal dominant spastic paraplegia after exclusion of SPG4 cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP708318.RAATlkQI814Qbq52W9XX7w1Xpt5JNUzWL1Ka6XXqTML3A130_assertion description "[This study enables us to estimate the frequency of the SPG3A mutations in France at 39% in families with young-onset autosomal dominant spastic paraplegia after exclusion of SPG4 cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708318.RAATlkQI814Qbq52W9XX7w1Xpt5JNUzWL1Ka6XXqTML3A130_provenance.
- NP699804.RARJ2JvuU34XPiNtPzRVnIt60-hlkd1_QA2E-YvkeeUqA130_assertion description "[This study enables us to estimate the frequency of the SPG3A mutations in France at 39% in families with young-onset autosomal dominant spastic paraplegia after exclusion of SPG4 cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699804.RARJ2JvuU34XPiNtPzRVnIt60-hlkd1_QA2E-YvkeeUqA130_provenance.
- NP710065.RAUZR1-J8JCaxIL6lTyLnTj3w3iJQL_hUzUaj41niNg4Y130_assertion description "[This study enables us to estimate the frequency of the SPG3A mutations in France at 39% in families with young-onset autosomal dominant spastic paraplegia after exclusion of SPG4 cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710065.RAUZR1-J8JCaxIL6lTyLnTj3w3iJQL_hUzUaj41niNg4Y130_provenance.
- assertion description "[This study enables us to estimate the frequency of the SPG3A mutations in France at 39% in families with young-onset autosomal dominant spastic paraplegia after exclusion of SPG4 cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP472581.RABCciGGPss3d6x1NuCTyR8xfU80UpWFWeDLyRDqJUPus130_assertion description "[This study enables us to estimate the frequency of the SPG3A mutations in France at 39% in families with young-onset autosomal dominant spastic paraplegia after exclusion of SPG4 cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472581.RABCciGGPss3d6x1NuCTyR8xfU80UpWFWeDLyRDqJUPus130_provenance.